Cargando…
In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
Hepatotoxicity remains an as yet unsolved problem for adenovirus (Ad) cancer therapy. The toxic effects originate both from rapid Kupffer cell (KCs) death (early phase) and hepatocyte transduction (late phase). Several host factors and capsid components are known to contribute to hepatotoxicity, how...
Autores principales: | Naumenko, Victor A., Vishnevskiy, Daniil A., Stepanenko, Aleksei A., Sosnovtseva, Anastasiia O., Chernysheva, Anastasiia A., Abakumova, Tatiana O., Valikhov, Marat P., Lipatova, Anastasiia V., Abakumov, Maxim A., Chekhonin, Vladimir P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313019/ https://www.ncbi.nlm.nih.gov/pubmed/35885002 http://dx.doi.org/10.3390/biomedicines10071697 |
Ejemplares similares
-
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation
por: Stepanenko, Aleksei A., et al.
Publicado: (2021) -
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures
por: Stepanenko, Aleksei A., et al.
Publicado: (2021) -
Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?
por: Naumenko, Victor A., et al.
Publicado: (2022) -
Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury
por: Sosnovtseva, Anastasiia O., et al.
Publicado: (2022) -
Neutrophil as a Carrier for Cancer Nanotherapeutics: A Comparative Study of Liposome, PLGA, and Magnetic Nanoparticles Delivery to Tumors
por: Garanina, Anastasiia S., et al.
Publicado: (2023)